Insider trade

Veradermics (MANE): Director sold ~$37.6M

Patrick G Enright, Director at Veradermics, sold ~$37.6M of Veradermics shares.

~$37.6M
Approx. value · 250K sh @ $150.38: 2.35M
Holds after · shares reported

Traded: Nov 11, 2026
Filed: Nov 13, 2026

Context

Written by software from the filings listed below · Nov 14, 2026

What was filed. Patrick G Enright, Director, reported an open-market sale of about $37.6M of Veradermics (MANE) shares (250,000 shares at $150.38 each). SEC Form 4

5 more points, with the facts they come from, are in OQRO Pro.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 13, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 5.6%
Nov 10, 2026Company filing · Form 8-K · ResultsReported its results
Nov 11, 2026 · this disclosureInsiderDirector sold ~$37.6M of MANE shares in the open market

What came next

Nov 11, 2026Insider · 2 peopleInsiders: 3 sales (~$112.8M)
Nov 13, 20265% stakePatrick G. Enright filed an activist stake (13D) of 9.8%

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Veradermics

For Veradermics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MANE page.

Other recent filings by Patrick G Enright, Director

The full history of Patrick G Enright, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Veradermics

Everything OQRO holds on this company is on its MANE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data